Licensing · Registration · Logistics · Marketing
Inteli Generics Nord · Maxpharma Baltija
An integrated pharmaceutical distribution partner — in‑licensing, registration, logistics and marketing across eight strategic markets.
If you own a product, a dossier or a marketing authorisation and want it registered and sold across Eastern Europe, the South Caucasus and Central Asia, we are the single partner who takes it the whole way — in-licensing, registration, market access, distribution and marketing. We cover eight markets in three regulatory blocks: the EU (Lithuania, Latvia, Estonia and Poland), the EAEU (Belarus and Kazakhstan) and national procedures (Ukraine and Azerbaijan). In Ukraine we operate directly through our subsidiary, LLC Eveya Pharma.
Inteli Generics Nord in-licenses medicinal products and acts as marketing-authorisation holder; Maxpharma Baltija manages product representation, GDP logistics and marketing. Together we hold more than 100 marketing authorisations and run the full cycle in-house — registration, pharmacovigilance, reimbursement listing, tender participation, distribution and promotion. We also offer service models — regulatory, MA-holding and logistics support — for companies that need a local presence without in-licensing.
We build our portfolio around products that hold critical positions in the healthcare system, with a focus on dermatology, CNS, urology, pharmaceutical iron, gastroenterology and migraine. We are actively looking for finished dosage forms to in-license or acquire (dossier / MA transfer) — if you are looking for a reliable licensee and local partner for our region, let's talk.
We operate successfully across every market segment
02 — Values
Only certified manufacturers make it into our portfolio. We guarantee full transparency and an audit-verified supply chain, giving national markets access to the highest-quality treatment solutions at a competitive price.
We guarantee maximum safety and full compliance with international standards. All products are handled and stored strictly under Good Distribution Practice (GDP) requirements, with continuous validated temperature-controlled monitoring.
One agreement — eight markets. A single partnership gives your product access to the EU, the EAEU and national markets from the Baltics to Central Asia, without you setting up local entities.
We build long-term, win-win relationships. Decades-proven ties with manufacturers, hospitals and pharmacy chains let us secure stable availability and grow market share for the products we take on.
03 — Numbers
04 — Certificates
All products are handled and stored under Good Distribution Practice (GDP) requirements, with continuous, validated temperature monitoring across our supply chain.
05 — What we do
06 — Contacts
Vito Gerulaičio g. 10
LT‑08200 Vilnius, Lithuania
Registered office: Saltoniškių g. 29, LT‑08106 Vilnius
07 — Write to us
Considering Maxpharma as your licensee and local partner? Tell us about the product, the dosage form and the markets you are interested in, and our business development team will come back to you quickly.
